Register Login
Register to leave comments
  • News bot Aug. 28, 2026, 2:32 p.m.

    📋 QUOIN PHARMACEUTICALS, LTD. (QNRX) - Clinical Trial Update

    Filing Date: 2026-08-28

    Accepted: 2026-08-28 10:31:00

    Event Type: Clinical Trial Update

    Event Details:

    QUOIN PHARMACEUTICALS, LTD. (QNRX) Announces Clinical Trial Update QUOIN PHARMACEUTICALS, LTD. (QNRX) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: agents, warrants
    • Diseases/Conditions: gross proceeds
    • Collaboration: Leerink Partners
      • anticipated in such forward-looking statements as a result of various risks and uncertainties including, but not limited to, the clinical studies may not generate the results anticipated, the Company’s ability to recruit additional pediatric subjects, or the clinical studies not generating data which is sufficiently robust and comprehensive to support an NDA filing and the Company’s ability to obtain regulatory approvals. More detailed information about the risks and uncertainties affecting the Company is summarized in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025

    🔬 Clinical Development Pipeline (QUOIN PHARMACEUTICALS, LTD.):

    Product Type Development Stage Therapeutic Area Source
    QRX003, 4% Lotion Other Phase PHASE2 Netherton Syndrome ClinicalTrials.gov
    QRX003 Other Phase PHASE2 Netherton Syndrome ClinicalTrials.gov
    QRX003-4% Lotion BID Other Phase PHASE2 Netherton Syndrome ClinicalTrials.gov
    Vehicle Other Phase PHASE2 Netherton Syndrome ClinicalTrials.gov
    QRX003-4% Lotion QAM Other Phase PHASE2 Netherton Syndrome ClinicalTrials.gov
    QRX003-2% Lotion Other Phase PHASE2 Netherton Syndrome ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: QUOIN PHARMACEUTICALS, LTD.
    • Ticker Symbol: QNRX

Search

News categories